Key result
Genetically predicted elevated serum remnant cholesterol levels were significantly associated with an increased risk of developing ischemic heart disease (OR 1.409).
Why the study?
Serum lipids are linked to cardiovascular diseases in observational studies, but causal inference between remnant cholesterol levels and risk of various cardiovascular diseases has not been established.
Does genetically predicted elevated remnant cholesterol increase the risk of cardiovascular diseases in European populations?
Population
Publicly released large-scale GWAS data
Comparison
Genetically predicted remnant cholesterol levels
Design
Bidirectional two-sample Mendelian randomization study
Authors
Loading...
Supports RC-lowering trials for CVD prevention; extends causal genetic evidence while leaving clinical adoption open.
Observational
Does genetically predicted elevated remnant cholesterol increase the risk of cardiovascular diseases in European populations?
Odds Ratio: 1.409 (95% CI 1.284–1.546)
p-value: p=4.753E-13
Genetically predicted elevated remnant cholesterol is causally associated with an increased risk of multiple cardiovascular diseases, suggesting it may be a valuable target for lipid-lowering therapy to reduce residual ASCVD risk.
Zhong et al. (2024) conducted an observational in Cardiovascular diseases. Remnant cholesterol vs. Lower remnant cholesterol levels was evaluated on Ischemic heart disease (OR 1.409, 95% CI 1.284-1.546, p=4.753E-13). Genetically predicted elevated serum remnant cholesterol levels were significantly associated with an increased risk of developing ischemic heart disease (OR 1.409).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: